NoCanTher in NanoPT - Oporto

03.02.2017

The Nanoscience and Nanotechnology International Conference of NanoPT, took place in Oporto, Portugal between the 1st and the 3rd of February. Oihane Ibarrola, Scientific Responsible for Process Technologies in Research and Development Division (Biopraxis), presented the talk about the Nocanther project under the title “Nanomedicine Upscaling for Early Clinical Phases of Multimodal Cancer Therapy” where the audience of academics and experts of the industry well received the presentation.

nanopt2017

NoCanTher Meeting in Paris

25.11.2017

The second meeting of the NoCanTher Project was held at Université Paris Diderot (UPD) on 24-25th November, kindly hosted by Florence Gazeau and the UPD team. Representatives from all partners were present and the meeting was a chance to report on all the exciting progress that has been made on the project so far.

Paris Meeting

On the first day Prof. Álvaro Somoza (IMDEA Nanociencia) gave an update of the global progress and then the work package leaders summarised the tasks to date. After a long day we had the chance to relax with a dinner kindly provided by Florence and UPD. The second day focused on the concrete plans for the next 6 months and culminated in the creation of the NoCanTher timeline during a lively discussion led by Simó Schwartz (VHIR).

Continue Reading

European Project Focused on the Development of Nanomedicines against Pancreatic Cancer

11.05.2016

The Kick-off meeting of the European Project NoCanTher was held at IMDEA Nanociencia (Madrid) on 10-11th May. During this meeting 35 researchers from the different organizations involved discussed the key issues to be addressed during the first year and the administrative procedures to ensure the success of this innovative project.

The project, financed with more than € 7 million, aims to scale-up a nanoformulation previously developed at IMDEA Nanociencia, for its use in clinical study for treatment of pancreatic cancer.

NoCanTher will be financed 100% by the EU (H2020 Grant No. 685795) and continues the efforts of a previous project (MULTIFUN FP7 Grant No. 262943) also scientifically coordinated at IMDEA Nanociencia. This time, it integrates a consortium of research centres, hospitals and enterprises from Spain, France, Germany, UK and Ireland. The consortium is made up of five Spanish partners: Spanish National Cancer Research Centre – CNIO, Vall d’Hebron Research Institute, Vall d’Hebron Institute of Oncology, Biopraxis, and IMDEA Nanociencia. The other European partners are Trinity College Dublin (Ireland), Jena University Hospital (Germany), Paris Diderot University (France) and the enterprises Resonant Circuits Limited (UK), Immupharma (UK) and Chemicell (Germany).

noticia imagen european project

NoCanTher at Fira de Recerca en Direct 2017

06.05.2017

More than 600 high school students have already had the chance to learn about our work with nanoparticles, our partners from Vall d'Hebron have been taking part in "Fira de Recerca Direct 2017" (Live Research Fair 2017). The fair is open to the general public (last day tomorrow 6th May), anyone can reach them at CosmoCaixa (Science Museum in Barcelona, C/Isaac Newton 26). 

This event, organized by the Scientific Culture Unit of the Barcelona Science Park with "la Caixa" Foundation, aims to show the current research projects in Catalonia in different fields of research, bringing it to the public and promoting scientific vocation of young students.

More Articles ...